NK-cell educating KIR/HLA combinations impact survival in anti-PD-L1 treated cancer patients https://www.medrxiv.org/content/10.1101/2022.12.06.22282592
QOTO: Question Others to Teach Ourselves An inclusive, Academic Freedom, instance All cultures welcome. Hate speech and harassment strictly forbidden.